Suchergebnisse - "Shah, Rashmi R"

PubPharm (147)

51

Inflammation-induced phenoconversion of polymorphic drug metabolizing enzymes : hypothesis with implications for personalized medicine

enthalten in: Drug metabolism and disposition: the biological fate of chemicals | 2015

von Shah, R. | Smith, R.

52

ICH E14 Q&A(R2) document : commentary on the further updated recommendations on thorough QT studies

enthalten in: British journal of clinical pharmacology | 2015

von Shah, R. | Morganroth, J. | Kleiman, R.

53

Addressing phenoconversion : the Achilles' heel of personalized medicine

enthalten in: British journal of clinical pharmacology | 2015

von Shah, R. | Smith, R.

CommentIn: Br J Clin Pharmacol. 2015 Oct;80(4):777-8. - PMID 25881716

54

Update on Cardiovascular Safety of Tyrosine Kinase Inhibitors: With a Special Focus on QT Interval, Left Ventricular Dysfunction and Overall Risk/Benefit

enthalten in: Drug safety | 2015

von Shah, R. | Morganroth, J.

55

Replacing the thorough QT study : reflections of a baby in the bath water

enthalten in: British journal of clinical pharmacology | 2014

von Kleiman, R. | Shah, R. | Morganroth, J.

56

Effect of tyrosine kinase inhibitors on wound healing and tissue repair : implications for surgery in cancer patients

enthalten in: Drug safety | 2014

von Shah, D. | Dholakia, S. | Shah, R.

57

Effect of Tyrosine Kinase Inhibitors on Wound Healing and Tissue Repair: Implications for Surgery in Cancer Patients

enthalten in: Medical toxicology | 2014

von Shah, D. | Dholakia, S. | Shah, R.

58

Effect of Tyrosine Kinase Inhibitors on Wound Healing and Tissue Repair: Implications for Surgery in Cancer Patients

enthalten in: Drug safety | 2014

von Shah, D. | Dholakia, S. | Shah, R.

59

Effect of Tyrosine Kinase Inhibitors on Wound Healing and Tissue Repair: Implications for Surgery in Cancer Patients

enthalten in: Drug safety | 2014

von Shah, D. | Dholakia, S. | Shah, R.

60

A fresh perspective on comparing the FDA and the CHMP/EMA : approval of antineoplastic tyrosine kinase inhibitors

enthalten in: British journal of clinical pharmacology | 2013

von Shah, R. | Roberts, S. | Shah, D.